Market Risers: Hardide Plc, GlaxoSmithKline plc, AstraZeneca plc, Imperial Brands PLC, London Stock Exchange Group Plc & Mediclinic International PLC

Hardide Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Shares of Hardide Plc ticker lookup code: LON:HDD has moved up 6.34% or 0.08 points during the course of today’s session so far. Traders have stayed positive during the session. Range high for the period has seen 1.5 and a low of 1.41. The total volume of shares exchanged so far has reached 850,921 whilst the daily average number of shares exchanged is just 334,698. The 52 week high for the shares is 2.3 about 0.97 points difference from the previous days close and putting the 52 week low at 1.25 a difference of some 0.08 points. Hardide Plc has a 20 SMA of 1.4 and also a 50 day moving average now of 1.47. Market capitalisation for the company is £23.84m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for Hardide Plc being recorded at Monday, December 10, 2018 at 11:15:20 AM GMT with the stock price trading at 1.41 GBX.

 

Shares of GlaxoSmithKline plc ticker code: LON:GSK has climbed 2.24% or 32.22 points during today’s session so far. Investors have stayed positive during the trading session. The periods high has reached 1474.8 dropping as low as 1435.54. The number of shares traded by this point in time totalled 2,036,509 with the daily average number around 11,978,889. The 52 week high price for the shares is 1648.8 amounting to 211.4 points in difference to the previous days close of business and a 52 week low sitting at 1179.39 which is a difference of 258.01 points. GlaxoSmithKline plc now has a 20 SMA at 1571.78 and now a 50 day moving average now of 1546.75. The current market capitalisation is £72,910.93m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for GlaxoSmithKline plc being recorded at Monday, December 10, 2018 at 12:03:19 PM GMT with the stock price trading at 1469.62 GBX.

 

The trading price for AstraZeneca plc with company EPIC: LON:AZN has climbed 2.75% or 163 points throughout the session so far. Buyers are a positive bunch during this period. The periods high figure was 6097 dipping to 5927. Volume total for shares traded at this point reached 503,601 with the daily average traded share volume around 2,659,542. The 52 week high price for the shares is 6432.48 some 505.48 points in difference on the previous days close and a 52 week low being 4544.5 which is a variance of 1382.5 points. AstraZeneca plc now has a 20 moving average of 6234.2 and now a 50 day moving average of 6048.2. The market capitalisation currently stands at £77,136.16m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Monday, December 10, 2018 at 12:03:15 PM GMT with the stock price trading at 6090 GBX.

 

Stock in Imperial Brands PLC with EPIC code: LON:IMB has stepped up 2.72% or 63.5 points in today’s trading session so far. Investors have remained positive while the stock has been in play. The period high has peaked at 2402.5 meanwhile the session low reached 2335. The total volume of shares exchanged through this period comes to 367,331 whilst the average number of shares exchanged is 3,091,033. The 52 week high for the share price is 3193.5 about 856 points in difference to the previous days close of business and a 52 week low sitting at 2298 a difference of some 39.5 points. Imperial Brands PLC now has a 20 moving average of 2528.9 and a 50 day moving average now of 2622.42. This puts the market cap at £22,899.22m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for Imperial Brands PLC being recorded at Monday, December 10, 2018 at 12:03:20 PM GMT with the stock price trading at 2401 GBX.

 

The trading price for London Stock Exchange Group Plc with company EPIC: LON:LSE has moved up 1.63% or 63.2 points during the course of today’s session so far. Traders have remained optimistic throughout the session. The high for the period has peaked at 3944 dipping to 3868. The amount of shares exchanged has so far reached 114,446 with the daily average number around 912,735. A 52 week high for the stock is 4814 which comes in at 941 points difference from the previous close and the 52 week low at 3612 which is a difference of 261 points. London Stock Exchange Group Plc now has a 20 SMA at 4096.3 and now its 50 day moving average at 4248.86. This puts the market cap at £13,704.20m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for London Stock Exchange Group Plc being recorded at Monday, December 10, 2018 at 12:03:20 PM GMT with the stock price trading at 3936.2 GBX.

 

Shares in Mediclinic International PLC found using EPIC: LON:MDC has climbed 1.21% or 4 points in today’s trading session so far. Investors are a positive bunch during this period. The periods high has reached 334.7 dropping as low as 327.2. The volume total for shares traded up to this point was 201,674 while the daily average number of shares exchanged is 4,369,101. The stock 52 week high is 712.4 which comes in at 382.1 points difference from the previous close and the 52 week low at 322.6 a difference of some 7.69 points. Mediclinic International PLC now has a 20 SMA of 358.43 and now the 50 day moving average of 391.06. The market capitalisation is now £2,464.61m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Mediclinic International PLC being recorded at Monday, December 10, 2018 at 12:02:08 PM GMT with the stock price trading at 334.3 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.
    AstraZeneca and Amgen's Tezspire shows promise in reducing nasal polyp size and congestion, offering hope for chronic rhinosinusitis patients.
    GSK Plc reports Q3 2024 results with strong growth in Specialty Medicines offsetting lower Vaccine sales. Core earnings rose by 5%, despite Zantac charges.
    AstraZeneca's Wainzua gains CHMP backing for EU approval in treating ATTRv-PN, marking a potential breakthrough with self-administered therapy.
    Hardide plc (LON: HDD) forecasts FY24 revenue at £4.7m, with improved H2 sales and a focus on driving growth through strategic business development.
    GSK's new antibiotic gepotidacin earns FDA's Priority Review, marking potential first new uUTI oral treatment in 20 years, with decision due March 2025.

      Search

      Search